Peera Ampornpan-Jaru

113 Thailand Science Park, Phahonyothin Road
Khlong Luang, 12120, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Superior magnitude and durability of hybrid immunity following SARS-CoV-2 infection.

Superior magnitude and durability of hybrid immunity following SARS-CoV-2 infection.

Journal: Asian Pacific journal of allergy and immunology

Published: June 02, 2026

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.

Journal: Vaccines

Published: March 14, 2026

Repurposing of the nucleoside analogs for influenza.

Repurposing of the nucleoside analogs for influenza.

Journal: Computational and structural biotechnology journal

Published: April 30, 2025

Synthesis and Modification of Cordycepin-Phosphoramidate ProTide Derivatives for Antiviral Activity and Metabolic Stability.

Synthesis and Modification of Cordycepin-Phosphoramidate ProTide Derivatives for Antiviral Activity and Metabolic Stability.

Journal: ACS bio & med chem Au

Published: August 01, 2024

PEDV nucleocapsid antagonizes zinc-finger antiviral protein by disrupting the interaction with its obligate co-factor, TRIM25.

PEDV nucleocapsid antagonizes zinc-finger antiviral protein by disrupting the interaction with its obligate co-factor, TRIM25.

Journal: Veterinary microbiology

Published: November 24, 2023

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.

Journal: Vaccine: X

Published: April 12, 2023

Self-enhancement lateral flow immunoassay for COVID-19 diagnosis.

Self-enhancement lateral flow immunoassay for COVID-19 diagnosis.

Journal: Sensors and actuators. B, Chemical

Published: January 29, 2023

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.

Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.

Journal: Vaccines

Published: January 03, 2023

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 01, 2022

Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants.

Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants.

Journal: Vaccines

Published: October 18, 2022

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.

Journal: Vaccine: X

Published: June 29, 2022

Zinc-finger antiviral protein-mediated inhibition of porcine epidemic diarrhea virus growth is antagonized by the coronaviral nucleocapsid protein.

Zinc-finger antiviral protein-mediated inhibition of porcine epidemic diarrhea virus growth is antagonized by the coronaviral nucleocapsid protein.

Journal: Frontiers in microbiology

Published: June 22, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026